Biocon (BIOCON) Share Price falls 2.06% as Biocon Share Price Today weakens
- October 7, 2026
- Posted by: Kunal Singla
- Category: News
Biocon Share Price fell to Rs 361, down 2.06% today, with a market capitalisation of Rs 60,257.94 Cr. According to latest Univest data, the move left Biocon lower than its previous close of Rs 368.60 after trading between Rs 369.95 and Rs 359.25. The stock’s latest session keeps Biocon Share Price in focus for readers tracking Biocon Share Price Today, Biocon Stock News and Biocon Share Price Fall.For investors following Univest, the key question is how today’s share price decline fits with valuation, profitability and sector positioning.
Biocon (BIOCON) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 361 |
| Previous Close | Rs 368.6 |
| Today's Move | -Rs 7.60 (-2.06%) |
| Open | Rs 369.95 |
| High | Rs 369.95 |
| Low | Rs 359.25 |
| Market Capitalisation | Rs 60,257.94 crore |
| Market Cap Category | Large Cap |
Biocon Share Price Today opened at Rs 369.95, matched the day’s high at Rs 369.95 and touched a low of Rs 359.25 before last trading at Rs 361. The decline of Rs 7.60 from the previous close of Rs 368.60 shows a 2.06% fall in the latest session. With a market capitalisation of Rs 60,257.94 Cr, Biocon remains a Large Cap company, so even a modest daily swing matters in the context of Biocon Share Price and Biocon Stock Performance. The range shows that the stock moved lower after the open and stayed near the lower end of the day’s band. For Univest readers, that sets up the next check: whether fundamentals and sector comparisons support the current Biocon Share Price level.
Why Biocon (BIOCON) May Be Moving Today
Biocon (BIOCON) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 60,257.94 crore |
| P/E Ratio | 121.28x |
| P/B Ratio | 1.77x |
| ROE | 1.35% |
| ROCE | 3.26% |
| EPS | Rs 3.04 |
| Book Value Per Share | Rs 208.53 |
| Dividend Yield | 0.14% |
Biocon (BIOCON) fundamental metrics show P/E 121.28x, P/B 1.77x, ROE 1.35%, ROCE 3.26%. These figures provide context only and are not a buy or sell signal.
Biocon has a market capitalisation of Rs 60,257.94 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 121.28x, P/B at 1.77x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 1.35% and ROCE of 3.26%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.04, book value per share of Rs 208.53, dividend yield of 0.14%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.15x, median ROE of 11.73%, median ROCE of 13.63%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 121.28x |
| Benchmark Median P/E | 32.15x |
| Benchmark Average P/E | 48.45x |
| Benchmark P/E Range | 3.58x to 695.67x |
| Company P/B Ratio | 1.77x |
| Benchmark Median P/B | 2.96x |
| Benchmark Average P/B | 4.32x |
| Company ROE | 1.35% |
| Benchmark Median ROE | 11.73% |
| Benchmark Average ROE | 10.6% |
| Company ROCE | 3.26% |
| Benchmark Median ROCE | 13.63% |
| Benchmark Average ROCE | 13.37% |
| Company Market Capitalisation | Rs 60,257.94 crore |
| Benchmark Median Market Cap | Rs 816.35 crore |
| Benchmark Average Market Cap | Rs 13,921.97 crore |
Biocon (BIOCON) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Biocon (BIOCON) has a P/E ratio of 121.28x, which is above the benchmark median of 32.15x, a difference of +277.23%. On its own, the P/E gap is a valuation reference point, not a trading call.
Biocon (BIOCON) has a ROE of 1.35%, which is below the benchmark median of 11.73%, a difference of -88.49%. Biocon (BIOCON) has a ROCE of 3.26%, which is below the benchmark median of 13.63%, a difference of -76.08%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,27,561.49 | 35.73 | 5 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,44,572.22 | 86.63 | 14.35 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,80,870.62 | 83.33 | 20.25 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,13,565.81 | 25.64 | 4.29 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,07,769.94 | 32.19 | 3.09 | 11.83 | 16 |
Biocon (BIOCON) has a P/E ratio of 121.28x compared with the displayed peer median of 35.73x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 1.35% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 3.26% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Biocon (BIOCON) has a market capitalisation of Rs 60,257.94 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Biocon
- Biocon Share Price fell 2.06% today and traded near the lower end of the day’s range.
- Biocon Share Price today is backed by a Large Cap market value of Rs 60,257.94 Cr.
- Biocon Share Price carries a P/E of 121.28, far above the industry median.
- Biocon Share Price shows ROE of 1.35% and ROCE of 3.26%, both below benchmark levels.
- Biocon Share Price is also being compared with listed healthcare peers on valuation and returns.
About Biocon
Biocon operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is part of India’s listed pharma universe and is tracked for its valuation, profitability and market position within the Large Cap segment. Biocon Share Price is often discussed alongside its earnings ratio, book value and return ratios because those numbers help explain how the market values the business. The company’s reported metrics show a business that is valued differently from many peers in the sector, which is why Biocon Share Price remains relevant to investors studying pharmaceutical stock performance on Univest.
Track Biocon Share Price on Univest
Use Biocon (BIOCON) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Biocon Share Price on Univest for live share price updates, fundamental ratios, 52-week levels and broader market insights. Biocon Share Price Today can be monitored alongside P/E, P/B, ROE, ROCE, EPS and book value, giving a fuller picture of stock analysis. Univest also helps readers compare Biocon Share Price with sector peers and follow the latest market context in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Biocon Share Price fall today?
Ans. Biocon Share Price fell 2.06% to Rs 361 today.The session ranged from Rs 369.95 to Rs 359.25.
What is Biocon Share Price Today?
Ans. Biocon Share Price Today is Rs 361. It traded below the previous close of Rs 368.60 after opening at Rs 369.95. The move keeps Biocon Stock News and price action in focus for readers.
What is Biocon's market capitalisation?
Ans. Biocon has a market capitalisation of Rs 60,257.94 Cr. That places it in the Large Cap category and well above the benchmark median market value in the same industry set tracked here.
Is Biocon expensive on earnings valuation?
Ans. Biocon’s P/E ratio is 121.28, which is far above the healthcare industry median of 32.15 and average of 48.45. On earnings valuation, Biocon Share Price sits at a premium to the sector group.
How do Biocon ROE and ROCE compare with peers?
Ans. Biocon’s ROE is 1.35% and ROCE is 3.26%. Both are below the benchmark medians of 11.73% and 13.63%, and also below the peer figures listed in the comparison set. Comparable listed companies include Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals.
What does Biocon P/B ratio indicate?
Ans. Biocon’s P/B ratio is 1.77, below the sector median of 2.96 and average of 4.32. That makes the book-value multiple less demanding than the earnings multiple currently attached to Biocon Share Price.
What are the key fundamentals behind Biocon Share Price?
Ans. The key fundamentals are P/E of 121.28, P/B of 1.77, ROE of 1.35%, ROCE of 3.26%, EPS of Rs 3.04, book value of Rs 208.53 and dividend yield of 0.14%.
How does Biocon compare with healthcare peers?
Ans. Among the listed peers, Biocon has the highest P/E in the set and lower ROE and ROCE than every peer shown. Its market capitalisation is also below Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals.
Should investors track Biocon Share Price on Univest?
Ans. Investors tracking Biocon Share Price can use Univest for live price updates, valuation ratios and sector context. The current move, benchmark comparison and peer profile make the stock relevant for ongoing watchlists.
